wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33414487-4090A579-087D-463E-8EDD-0BE8AA4EBD89
Q33414487-4090A579-087D-463E-8EDD-0BE8AA4EBD89
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33414487-4090A579-087D-463E-8EDD-0BE8AA4EBD89
Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up.
P2860
Q33414487-4090A579-087D-463E-8EDD-0BE8AA4EBD89
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33414487-4090A579-087D-463E-8EDD-0BE8AA4EBD89
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6e0740ce3437f0267556f313ae424ed20fe9be62
P2860
Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure